scPharmaceuticals (SCPH) Revenue & Revenue Breakdown
scPharmaceuticals Revenue Highlights
Latest Revenue (Y)
$36.33M
Latest Revenue (Q)
$12.15M
scPharmaceuticals Revenue by Period
scPharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $36.33M | 167.28% |
| 2023-12-31 | $13.59M | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | - |
scPharmaceuticals generated $36.33M in revenue during NA 2024, up 167.28% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
scPharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $12.15M | 21.18% |
| 2024-09-30 | $10.03M | 24.48% |
| 2024-06-30 | $8.05M | 31.99% |
| 2024-03-31 | $6.10M | 0.10% |
| 2023-12-31 | $6.10M | 60.59% |
| 2023-09-30 | $3.80M | 131.75% |
| 2023-06-30 | $1.64M | -20.60% |
| 2023-03-31 | $2.06M | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | - |
scPharmaceuticals generated $12.15M in revenue during Q4 2024, up 21.18% compared to the previous quarter, and up 320.07% compared to the same period a year ago.
scPharmaceuticals Revenue Breakdown
scPharmaceuticals Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Mar 25 |
|---|---|
| Operating Segments | $11.75M |
Latest
scPharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Operating Segments (100.00%).
scPharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IOVA | Iovance Biotherapeutics | $164.07M | $73.69M |
| SCPH | scPharmaceuticals | $36.33M | $12.15M |
| LYRA | Lyra Therapeutics | $1.53M | $209.00K |
| MCRB | Seres Therapeutics | - | - |
| DMAC | DiaMedica Therapeutics | - | - |
| CNTA | Centessa Pharmaceuticals | - | - |
| MIST | Milestone Pharmaceuticals | - | - |
| MNPR | Monopar Therapeutics | - | - |
| ONCY | Oncolytics Biotech | - | - |
| KTTA | Pasithea Therapeutics | - | - |